 FOSTER CITY, Calif., March 29, 2021 GLOBE NEWSWIRE -- Vaxcyte, Inc. Nasdaq: PCVX, a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced financial results for the fourth quarter and full year ended December 31, 2020 and provided a business update. 